Biofrontera Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 120 PRESIDENTIAL WAY,, WOBURN, MA, 01801
Mailing Address 120 PRESIDENTIAL WAY,, WOBURN, MA, 01801
Phone 781-245-1325
Fiscal Year End 1231
EIN 473765675
Financial Overview
FY2024
$23.88M
Stockholders' Equity
$5.91M
Cash & Equivalents
$-3.22
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 11, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 28, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 8-K Current report of material events | January 7, 2026 | View on SEC |
| S-1 IPO registration statement | December 5, 2025 | View on SEC |
| 8-K Current report of material events | November 13, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 12, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 8-K Current report of material events | November 10, 2025 | View on SEC |
Material Events
8-K Financial Distress January 7, 2026
High Impact
- Biofrontera Inc. received a Nasdaq warning notice for failing to maintain a minimum stock price of $1.00.
- The company's stock traded below $1.00 for 34 consecutive business days, triggering the non-compliance notice.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.